Gaps in the care of patients admitted to hospital with an exacerbation of chronic obstructive pulmonary disease

CMAJ. Canadian Medical Association Journal

Volumn 170, Issue 9, 2004, Pages 1409-1413

  Choi, Perry P ^a   Day, Anna ^a   Etchells, Edward ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON DIOXIDE; STEROID;

BICARBONATE BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEATH; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE SEVERITY; HEALTH CARE; HEART ARREST; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; METERED DOSE INHALER; OXYGEN SATURATION; PALLIATIVE THERAPY; PATIENT CARE; RESPIRATORY CARE; RESPIRATORY TRACT DISEASE; REVIEW; TECHNIQUE;

EID: 2342528976     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1030713     Document Type: Review

References (26)

1. Canadian Institute for Health Information, Canadian Lung Association, Health Canada, Statistics Canada. Respiratory disease in Canada. Ottawa: Health Canada; 2001.
2. Geraci JM, Ashton CM, Kuykendall DH, Johnson ML, Wu L. In-hospital complications among survivors of admission for congestive heart failure, chronic obstructive pulmonary disease, or diabetes mellitus. J Gen Intern Med 1995;10:307-14.
3. Geraci JM, Ashton CM, Kuykendall DH, Johnson ML, Souchek J, del Junco D, et al. The association of quality of care and occurrence of in-hospital, treatment-related complications. Med Care 1999;37:140-8.
4. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:580-4.
5. Osman LM, Godden DJ, Friend JAR, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52:67-71.
6. Lau ACW, Yam LYC, Poon E. Hospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Med 2001;95:876-84.
7. Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, et al. Mortality after hospitalization for COPD. Chest 2002;121:1441-8.
8. International classification of diseases, 9th rev. (clinical modification). 5th ed. Washington: US Department of Health and Human Services; 1996.
9. George CF, Bayliff CD. Management of insomnia in patients with chronic obstructive pulmonary disease. Drugs 2003;63:379-87.
10. Salpeter SS, Ormiston T, Salpeter E, Poole P, Cates C. Cardioselective beta-blockers for chronic obstructive pulmonary disease [Cochrane review]. In: The Cochrane Library; Issue 1, 2003. Oxford: Update Software.
11. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism. Chest 2001;199:132S-75S.
12. Sin DD, Bell NR, Svenson LW, Man SFP. The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study. Am J Med 2002;112:120-5.
13. Narsavage GL, Naylor MD. Factors associated with referral of elderly individuals with cardiac and pulmonary disorders for home care services following hospital discharge. J Gerontol Nurs 2000;26(5):14-20.
14. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001;163:1256-76.
15. Canadian Respiratory Review Panel. Guidelines for the treatment of chronic obstructive pulmonary disease. 1st ed. Toronto: Medication Use Management Services; 1998.
16. COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52(S5):S1-28.
17. Snow V, Lascher S, Mottur-Pilson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Am Intern Med 2001;134:595-9.
18. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105:111-6.
19. Larsen JS, Hahn M, Ekholm B, Wick KA. Evaluation of conventional press-and-breathe metered-dose inhaler technique in 501 patients. J Asthma 1994;31:193-9.
20. Van Beerendonk I, Mesters J, Mudde AN, Tan TD. Assessment of the inhalation using a metered-dose inhaler or dry powder device. J Asthma 1998;35:273-9.
21. Shrestha M, Parupia H, Andrews B, Kim SW, Martin MS, Park DI, et al. Metered-dose inhaler technique of patients in an urban ED: prevalence of incorrect technique and attempt at education. Am J Emerg Med 1996;14:380-4.
22. Johnson DH, Robart P. Inhaler technique of outpatients in the home. Respir Care 2000;45:1182-7.
23. Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med 1996;156:984-8.
24. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995;274:35-43.
25. Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma'Luf N, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999;6:313-21.
26. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.